3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
139
Breast Neoplasms
31
Prostatic Neoplasms
29
Insulin Resistance
28
Obesity
19
Pancreatic Neoplasms
13
Neoplasms
12
Infertility
12
Endometrial Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Colorectal Neoplasms
11
Anovulation
9
Lung Neoplasms
8
Metabolic Syndrome
7
Melanoma
7
Hyperandrogenism
7
Glioblastoma
7
Diabetes Mellitus
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Rectal Neoplasms
5
Adenocarcinoma
5
Weight Loss
4
Urinary Bladder Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma of Lung
4
Uterine Cervical Neoplasms
3
Recurrence
3
Interventions
peginterferon alfa-2a
2
Ribavirin
2
ledipasvir
1
Metformin
1
Introns
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis C, Chronic
×
Metformin
×
Clear all
NCT02319200
2017-01-11
METFOVIR
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
11 enrolled